- Home
- LMT vs BMY Comparison
LMT vs BMY Comparison
Compare LMT & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMT
- BMY
- Stock Information
- Founded
- LMT 1912
- BMY 1887
- Country
- LMT United States
- BMY United States
- Employees
- LMT N/A
- BMY N/A
- Industry
- LMT Military/Government/Technical
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- LMT Industrials
- BMY Health Care
- Exchange
- LMT Nasdaq
- BMY Nasdaq
- Market Cap
- LMT 121.6B
- BMY 115.2B
- IPO Year
- LMT N/A
- BMY N/A
- Fundamental
- Price
- LMT $490.37
- BMY $56.30
- Analyst Decision
- LMT Buy
- BMY Hold
- Analyst Count
- LMT 12
- BMY 15
- Target Price
- LMT $588.25
- BMY $56.29
- AVG Volume (30 Days)
- LMT 1.2M
- BMY 10.8M
- Earning Date
- LMT 01-28-2025
- BMY 02-06-2025
- Dividend Yield
- LMT 2.69%
- BMY 4.41%
- EPS Growth
- LMT 0.98
- BMY N/A
- EPS
- LMT 27.67
- BMY N/A
- Revenue
- LMT $71,295,000,000.00
- BMY $47,435,000,000.00
- Revenue This Year
- LMT $6.49
- BMY $7.22
- Revenue Next Year
- LMT $3.88
- BMY $0.24
- P/E Ratio
- LMT $17.72
- BMY N/A
- Revenue Growth
- LMT 5.33
- BMY 5.56
- 52 Week Low
- LMT $413.92
- BMY $39.35
- 52 Week High
- LMT $618.95
- BMY $61.08
- Technical
- Relative Strength Index (RSI)
- LMT 49.80
- BMY 47.26
- Support Level
- LMT $461.24
- BMY $55.08
- Resistance Level
- LMT $487.76
- BMY $56.74
- Average True Range (ATR)
- LMT 7.86
- BMY 0.99
- MACD
- LMT 3.49
- BMY -0.07
- Stochastic Oscillator
- LMT 90.58
- BMY 41.74
About LMT Lockheed Martin Corporation
Lockheed Martin is the world's largest defense contractor and has dominated the Western market for high-end fighter aircraft since it won the F-35 Joint Strike Fighter program in 2001. Lockheed's largest segment is aeronautics, which derives upward of two-thirds of its revenue from the F-35. Lockheed's remaining segments are rotary and mission systems, mainly encompassing the Sikorsky helicopter business; missiles and fire control, which creates missiles and missile defense systems; and space systems, which produces satellites and receives equity income from the United Launch Alliance joint venture.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.